The current BSX market cap is 122.86B. The company's latest EPS is USD 1.0661 and P/E is 77.45.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 3.6B | 3.64B | 3.73B | 3.86B | 4.12B |
Operating Income | 515M | 736M | 541M | 673M | 521M |
Net Income | 261M | 504M | 505M | 495M | 324M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 10.77B | 10.01B | 11.89B | 12.68B | 14.35B |
Operating Income | 1.52B | -79M | 984M | 1.67B | 2.34B |
Net Income | 4.7B | -115M | 985M | 642M | 1.57B |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 33.6B | 34.04B | 35.14B | 36.67B | 37.11B |
Total Liabilities | 15.12B | 14.91B | 15.61B | 16.5B | 16.5B |
Total Equity | 18.49B | 19.13B | 19.53B | 20.17B | 20.61B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 30.57B | 30.78B | 32.23B | 32.47B | 35.14B |
Total Liabilities | 16.69B | 15.45B | 15.61B | 14.9B | 15.61B |
Total Equity | 13.88B | 15.33B | 16.62B | 17.57B | 19.53B |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 848M | 1.55B | 2.5B | 164M | 977M |
Investing | -1.32B | -1.52B | -2.57B | -285M | -556M |
Financing | -26M | -10M | 5M | 1.57B | 1.59B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 1.84B | 1.51B | 1.87B | 1.53B | 2.5B |
Investing | -5.04B | -411M | -1.6B | -2.01B | -2.57B |
Financing | 2.97B | 293M | -95M | -548M | 5M |
Market Cap | 122.86B |
Price to Earnings Ratio | 77.45 |
Price to Sales Ratio | 8.47 |
Price to Cash Ratio | 140.57 |
Price to Book Ratio | 6.23 |
Dividend Yield | - |
Shares Outstanding | 1.47B |
Average Volume (1 week) | 4.82M |
Average Volume (1 Month) | 4.65M |
52 Week Change | 57.86% |
52 Week High | 84.115 |
52 Week Low | 48.35 |
Spread (Intraday) | 2.71 (3.21%) |
Company Name | Boston Scientific Corporation |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.bostonscientific.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.